Literature DB >> 1714795

Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression.

J R Ortaldo1, R T Winkler-Pickett, H Yagita, H A Young.   

Abstract

Both CD3- and CD3+ CD56+ effector cells can mediate non-MHC-restricted lysis in the absence of activation. Previous studies have shown that both of these subsets can be augmented with IL-2. In the present study, we have examined further the phenotypic markers expressed on these cells as well as the functional capacities of these subsets, including LAK activity, cytokine expression, and pore-forming protein (PFP) production. In addition, these populations were analyzed for clonality by Southern blot analysis of the T cell receptor beta chain gene constant region. The CD3-, CD56+ and CD3+, CD56+ lymphocytes were quite similar in their phenotypic markers, although the CD3+, CD56+ lymphocytes lacked high levels of IL-2 receptor beta chain and did not express CD16. The CD3+, CD56+ lymphocytes mediated non-MHC-restricted lysis, but failed to express LAK activity or be induced by IL-2 to secrete IFN gamma, a characteristic of the CD3-, CD56+ lymphocytes. The T cell receptor beta chain gene pattern of the CD3+, CD56+ lymphocytes was characteristic of a polyclonal cell population. Of interest, both populations of cells appeared morphologically to be large granular lymphocytes that contain PFP in their cytoplasmic granules. Therefore these CD56+ subsets provide a new model to study several questions related to non-MHC-restricted target cell lysis, including the identification of novel receptors involved in target cell recognition and/or triggering as well as the biochemical pathways implicated in cellular lysis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1714795     DOI: 10.1016/0008-8749(91)90369-m

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  25 in total

1.  IL-15-induced conversion of monocytes to mature dendritic cells.

Authors:  K U Saikh; A S Khan; T Kissner; R G Ulrich
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

2.  Dendritic cells pulsed with total tumor RNA for activation NK-like T cells against glioblastoma multiforme.

Authors:  Prachya Vichchatorn; Adisak Wongkajornsilp; Sawang Petvises; Sumalee Tangpradabkul; Samart Pakakasama; Suradej Hongeng
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

3.  CD56+ T cells inhibit HIV-1 infection of macrophages.

Authors:  Wei Hou; Li Ye; Wen-Zhe Ho
Journal:  J Leukoc Biol       Date:  2012-05-16       Impact factor: 4.962

4.  CD3+CD56+ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis.

Authors:  A Koreck; A Surányi; B J Szöny; A Farkas; Z Bata-Csörgö; L Kemény; A Dobozy
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

5.  Generation of CD3+ CD56+ cytokine-induced killer cells and their in vitro cytotoxicity against pediatric cancer cells.

Authors:  Suradej Hongeng; Sawang Petvises; Surapon Worapongpaiboon; Busaba Rerkamnuaychoke; Samart Pakakasama; Saengsuree Jootar
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

6.  CD161 DEFINES EFFECTOR T CELLS THAT EXPRESS LIGHT AND RESPOND TO TL1A-DR3 SIGNALING.

Authors:  O Cohavy; D Q Shih; T M Doherty; C F Ware; S R Targan
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

7.  Changes in natural immunity during the course of HIV-1 infection.

Authors:  B G Brenner; C Gryllis; M Gornitsky; M A Wainberg
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

8.  Activation of the immune system of cancer patients by continuous i.v. recombinant IL-2 (rIL-2) therapy is dependent on dose and schedule of rIL-2.

Authors:  J W Gratama; R J Bruin; C H Lamers; R Oosterom; E Braakman; G Stoter; R L Bolhuis
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

9.  Development of functional human NK cells in an immunodeficient mouse model with the ability to provide protection against tumor challenge.

Authors:  Amanda Kwant-Mitchell; Elishka A Pek; Kenneth L Rosenthal; Ali A Ashkar
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

10.  Regulation of HLA-DR and co-stimulatory molecule expression on natural killer T cells by granulocyte-macrophage colony-stimulating factor.

Authors:  Kamal U Saikh; Teri Kissner; Robert G Ulrich
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.